Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2012
06/28/2012US20120165287 Combined treatment of cancer by urokinase inhibition and a cytostatic anti-cancer agent for enhancing the anti-metastatic effect
06/28/2012US20120165285 Combined preparation for use as a medicament
06/28/2012US20120165281 Stilbenoid derivatives and their uses
06/28/2012US20120165278 Pyrroloquinolinyl-Pyrrolidine-2,5-Dione Compositions And Methods For Preparing And Using Same
06/28/2012US20120165277 Novel galactoside inhibitors of galectins
06/28/2012US20120165269 Tumor Cell-Killing Peptides
06/28/2012US20120165268 P53 fusion proteins and methods of making and using thereof
06/28/2012US20120165267 Apo-2 LIGAND/TRAIL VARIANTS AND USES THEREOF
06/28/2012US20120165260 Crystalline ezatiostat hydrochloride ansolvate
06/28/2012US20120165253 Pharmaceutical composition for inhibiting peritoneal dissemination
06/28/2012US20120165244 Methods for binding lewis y antigen
06/28/2012US20120164241 Boehmeria extract and its use in treating liver diseases
06/28/2012US20120164238 Methods of detecting colorectal cancer
06/28/2012US20120164215 Topical co-enzyme q10 formulations and methods of use
06/28/2012US20120164211 Compositions and methods for treating lymphoma
06/28/2012US20120164210 Photodynamic therapeutic agent having cell-specific active accumulation properties
06/28/2012US20120164181 Non-Specific Immunostimulating Agents
06/28/2012US20120164180 Cancer Vaccines and Therapeutic Methods
06/28/2012US20120164174 Adjuvant composition containing poly-gamma-glutamic acid-chitosan nanoparticles
06/28/2012US20120164172 Cancer Therapy
06/28/2012US20120164168 B7-dc variants immunogenic compositions and methods of use thereof
06/28/2012US20120164164 Multimeric polypeptides of hla-g including alpha1-alpha3 monomers and pharmaceutical uses thereof
06/28/2012US20120164163 Cdc45l peptides and vaccines including the same
06/28/2012US20120164161 Antibodies and Uses Thereof
06/28/2012US20120164160 Monoclonal antibodies against claudin-18 for treatment of cancer
06/28/2012US20120164148 Compositions Containing JARID1B Inhibitors and Methods for Treating Cancer
06/28/2012US20120164146 Isolated monophosphorylated peptide derived from human alpha-enolase useful for diagnosis and treatment of pancreatic adenocarcinoma, antibodies directed against the said monophosphorylated peptide, and uses thereof
06/28/2012US20120164143 Human monoclonal antibodies against interleukin 8 (il-8)
06/28/2012US20120164142 Compositions comprising natriuretic peptides and methods of use thereof
06/28/2012US20120164141 Methods and compositions for inducing apoptosis
06/28/2012US20120164137 Anti-folate receptor alpha antibody glycoforms
06/28/2012US20120164136 Compositions and Methods for Treatment of Cancer by Disrupting the LH/LHR Signaling Pathway
06/28/2012US20120164132 Anticancer and immunomodulating molecules and fractions containing said molecules, and process for preparing said fractions and said molecules from fermented vegetal material, and their uses
06/28/2012US20120164131 Modified mutant collagenase and it's use in fat melting and in scar reduction
06/28/2012US20120164122 Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases
06/28/2012US20120164108 Virus strains
06/28/2012US20120164107 Cyclic di-amp induction of type i interferon
06/28/2012US20120164104 Composition and Methods of Treating Viral Infections and Viral Induced Tumors
06/28/2012US20120164101 Gm-csf and interleukin-21 conjugates and uses thereof in the modulation of immune response and treatment of cancer
06/28/2012US20120164099 Use of human prostate cell lines in cancer treatment
06/28/2012US20120164076 Methods of treatment using thymus-derived compositions
06/28/2012US20120164074 Methods of diagnosing, preventing and treating cancer metastasis
06/28/2012US20120164072 Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
06/28/2012US20120164071 Compositions and Methods Comprising Phosphatidylethanolamine-Binding Peptide Derivatives
06/28/2012US20120164070 Benzothiazole and benzooxazole derivatives and methods of use
06/28/2012US20120164068 Immuno-conjugates and methods for producing them
06/28/2012US20120164066 Antigen-binding proteins comprising recombinant protein scaffolds
06/28/2012US20120164065 Method and composition for treating cancer
06/28/2012DE102010056443A1 New chlorin derivative useful as photosensitizer in photodynamic tumor therapy
06/28/2012CA2824278A1 Modulating agonistic tnfr antibodies
06/28/2012CA2822701A1 Novel pharmaceutical composition
06/28/2012CA2822565A1 Bi-heteroaryl compounds as vps34 inhibitors
06/28/2012CA2822432A1 Bicyclic pkm2 activators
06/28/2012CA2822360A1 Ingenol-3-acylates i
06/28/2012CA2822312A1 3-acyl-ingenols ii
06/28/2012CA2822310A1 Ingenol-3-acylates iii and ingenol-3-carbamates
06/28/2012CA2822070A1 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/28/2012CA2821638A1 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
06/28/2012CA2821546A1 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives
06/28/2012CA2821378A1 Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
06/28/2012CA2821230A1 Pharmaceutical compositions of pyridinium and quinolinium derivatives
06/28/2012CA2819269A1 Anti-mesothelin antibodies and immunoconjugates
06/28/2012CA2819041A1 Cyclic nucleotide analogs
06/28/2012CA2817688A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
06/27/2012EP2468868A1 Chemotherapeutic sensitizers
06/27/2012EP2468866A1 Biologically active oligonucleotides capable of modulating the immune system
06/27/2012EP2468865A1 Antisense oligonucleotide modulation of stat3 expression
06/27/2012EP2468861A1 Method of constructing gene transport support
06/27/2012EP2468776A2 Anti-Robo4 antibodies and uses therefor
06/27/2012EP2468775A1 Anti-ICAM1 antibodies for inducing apoptosis
06/27/2012EP2468772A2 Antibodies to EGFL7 and methods for their use
06/27/2012EP2468771A1 Pharmaceutical composition containing anti-hb-egf antibody as active ingredient
06/27/2012EP2468748A1 Pyrazoloquinolones are potent parp inhibitors
06/27/2012EP2468747A1 2-Selenophene-4-quinolones as anticancer agents
06/27/2012EP2468745A1 Process for the preparation of lapatinib and the salts thereof
06/27/2012EP2468734A1 Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry
06/27/2012EP2468730A1 Substituted hydrazide compounds and application thereof
06/27/2012EP2468726A1 Compound for the treatment of tumours and tumour metastases
06/27/2012EP2468281A1 Quinoline derivative-containing pharmaceutical composition
06/27/2012EP2468277A1 Triptolide derivatives for modulation of apoptosis and immunosuppression
06/27/2012EP2468260A2 Liposomes covered with the extracellular domain of the apo2l/trail protein
06/27/2012EP2468259A1 Pharmaceutical compositions of pyridinium and quinolinium derivatives
06/27/2012EP2467499A1 Cstf2 for target genes of lung cancer therapy and diagnosis
06/27/2012EP2467387A1 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
06/27/2012EP2467383A1 Heterocyclic oxime compounds
06/27/2012EP2467380A2 Substituted benzoazepines as toll-like receptor modulators
06/27/2012EP2467377A2 Substituted benzoazepines as toll-like receptor modulators
06/27/2012EP2467366A1 Novel fxr (nr1h4 ) binding and activity modulating compounds
06/27/2012EP2467359A2 (bis) urea and (bis) thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders
06/27/2012EP2467154A2 Tumoricidal, bactericidal, or viricidal macrophage activation
06/27/2012EP2467142A2 Heat shock protein binding compounds, compositions, and methods for making and using same
06/27/2012EP2467141A1 Heterocyclic compounds and uses thereof
06/27/2012EP2467140A2 Method of threating cancer
06/27/2012EP2467018A1 Phytoceutical compositions for pets
06/27/2012EP2280952B1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
06/27/2012EP2235021B1 Epoxy-guaiane derivatives and treatment of cancer
06/27/2012EP2222166B1 Heterocyclic kinase inhibitors
06/27/2012EP2215089B1 [1h- pyrazolo [3, 4-b]pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
06/27/2012EP2188263B1 Benzimidazole derivatives used as fxr agonists
06/27/2012EP2114980B1 Antiviral nucleoside analogs
1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 2211